nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Tachycardia—Vinorelbine—ovarian cancer	0.00209	0.00209	CcSEcCtD
Vancomycin—Skin disorder—Vinorelbine—ovarian cancer	0.00208	0.00208	CcSEcCtD
Vancomycin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00207	0.00207	CcSEcCtD
Vancomycin—Bradycardia—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Vancomycin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00204	0.00204	CcSEcCtD
Vancomycin—Asthenia—Chlorambucil—ovarian cancer	0.00202	0.00202	CcSEcCtD
Vancomycin—Neutropenia—Docetaxel—ovarian cancer	0.00201	0.00201	CcSEcCtD
Vancomycin—Hypotension—Vinorelbine—ovarian cancer	0.002	0.002	CcSEcCtD
Vancomycin—Oedema peripheral—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Vancomycin—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Pruritus—Chlorambucil—ovarian cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Urticaria—Topotecan—ovarian cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Body temperature increased—Topotecan—ovarian cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Abdominal pain—Topotecan—ovarian cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Urticaria—Melphalan—ovarian cancer	0.00195	0.00195	CcSEcCtD
Vancomycin—Phlebitis—Epirubicin—ovarian cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Thrombophlebitis—Epirubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Vancomycin—Erythema multiforme—Paclitaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Infestation NOS—Docetaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Infestation—Docetaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Dyspnoea—Vinorelbine—ovarian cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Tinnitus—Paclitaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Vancomycin—Renal failure—Docetaxel—ovarian cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Flushing—Paclitaxel—ovarian cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00185	0.00185	CcSEcCtD
Vancomycin—Fatigue—Vinorelbine—ovarian cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Hypersensitivity—Topotecan—ovarian cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Constipation—Vinorelbine—ovarian cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Pain—Vinorelbine—ovarian cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Chills—Paclitaxel—ovarian cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Hypersensitivity—Melphalan—ovarian cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Phlebitis—Doxorubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Asthenia—Topotecan—ovarian cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Vomiting—Chlorambucil—ovarian cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Agranulocytosis—Docetaxel—ovarian cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Pruritus—Topotecan—ovarian cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Erythema—Paclitaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Malnutrition—Paclitaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Renal impairment—Epirubicin—ovarian cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Asthenia—Melphalan—ovarian cancer	0.00176	0.00176	CcSEcCtD
Vancomycin—Dermatitis bullous—Epirubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Flatulence—Paclitaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Vancomycin—Pruritus—Melphalan—ovarian cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Back pain—Paclitaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Urticaria—Vinorelbine—ovarian cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Muscle spasms—Paclitaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Abdominal pain—Vinorelbine—ovarian cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Body temperature increased—Vinorelbine—ovarian cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Oedema peripheral—Docetaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Connective tissue disorder—Docetaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Nausea—Chlorambucil—ovarian cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Dizziness—Topotecan—ovarian cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Anaemia—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—ovarian cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Erythema multiforme—Docetaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.0016	0.0016	CcSEcCtD
Vancomycin—Flushing—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Vomiting—Topotecan—ovarian cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Vertigo—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Rash—Topotecan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Dermatitis—Topotecan—ovarian cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Blood creatinine increased—Epirubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Headache—Topotecan—ovarian cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Palpitations—Paclitaxel—ovarian cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Vomiting—Melphalan—ovarian cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Rash—Melphalan—ovarian cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Dermatitis—Melphalan—ovarian cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Chills—Docetaxel—ovarian cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Asthenia—Vinorelbine—ovarian cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Hypokalaemia—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Pruritus—Vinorelbine—ovarian cancer	0.00151	0.00151	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Vancomycin—Erythema—Docetaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Malnutrition—Docetaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Nausea—Topotecan—ovarian cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Nausea—Melphalan—ovarian cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Back pain—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Vancomycin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Muscle spasms—Docetaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Eosinophilia—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Infection—Paclitaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Dizziness—Vinorelbine—ovarian cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Tachycardia—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Skin disorder—Paclitaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Anaemia—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Vomiting—Vinorelbine—ovarian cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Neutropenia—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Rash—Vinorelbine—ovarian cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Dermatitis—Vinorelbine—ovarian cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Hypotension—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Headache—Vinorelbine—ovarian cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Palpitations—Docetaxel—ovarian cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Insomnia—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Vancomycin—Infestation NOS—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Vancomycin—Infestation—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Vancomycin—Dyspnoea—Paclitaxel—ovarian cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Nausea—Vinorelbine—ovarian cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Renal failure—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Urinary tract infection—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Fatigue—Paclitaxel—ovarian cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Constipation—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Pain—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Infection—Docetaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Agranulocytosis—Epirubicin—ovarian cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Nervous system disorder—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Tachycardia—Docetaxel—ovarian cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Skin disorder—Docetaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Bradycardia—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Urticaria—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Oedema peripheral—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Hypotension—Docetaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Connective tissue disorder—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Abdominal pain—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Body temperature increased—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Vancomycin—Insomnia—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Vancomycin—Erythema multiforme—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Dyspnoea—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Tinnitus—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Flushing—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Fatigue—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Constipation—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Pain—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Chills—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Asthenia—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Vancomycin—Pruritus—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Erythema—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Malnutrition—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—ovarian cancer	0.000999	0.000999	CcSEcCtD
Vancomycin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000997	0.000997	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—ovarian cancer	0.000994	0.000994	CcSEcCtD
Vancomycin—Flatulence—Epirubicin—ovarian cancer	0.000993	0.000993	CcSEcCtD
Vancomycin—Back pain—Epirubicin—ovarian cancer	0.000975	0.000975	CcSEcCtD
Vancomycin—Muscle spasms—Epirubicin—ovarian cancer	0.000969	0.000969	CcSEcCtD
Vancomycin—Body temperature increased—Docetaxel—ovarian cancer	0.000964	0.000964	CcSEcCtD
Vancomycin—Abdominal pain—Docetaxel—ovarian cancer	0.000964	0.000964	CcSEcCtD
Vancomycin—Chills—Doxorubicin—ovarian cancer	0.000961	0.000961	CcSEcCtD
Vancomycin—Dizziness—Paclitaxel—ovarian cancer	0.000951	0.000951	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—ovarian cancer	0.000933	0.000933	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—ovarian cancer	0.000933	0.000933	CcSEcCtD
Vancomycin—Anaemia—Epirubicin—ovarian cancer	0.000932	0.000932	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Vancomycin—Vomiting—Paclitaxel—ovarian cancer	0.000915	0.000915	CcSEcCtD
Vancomycin—Rash—Paclitaxel—ovarian cancer	0.000907	0.000907	CcSEcCtD
Vancomycin—Dermatitis—Paclitaxel—ovarian cancer	0.000906	0.000906	CcSEcCtD
Vancomycin—Vertigo—Epirubicin—ovarian cancer	0.000906	0.000906	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—ovarian cancer	0.000902	0.000902	CcSEcCtD
Vancomycin—Headache—Paclitaxel—ovarian cancer	0.000901	0.000901	CcSEcCtD
Vancomycin—Hypersensitivity—Docetaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—ovarian cancer	0.000897	0.000897	CcSEcCtD
Vancomycin—Palpitations—Epirubicin—ovarian cancer	0.000891	0.000891	CcSEcCtD
Vancomycin—Asthenia—Docetaxel—ovarian cancer	0.000875	0.000875	CcSEcCtD
Vancomycin—Pruritus—Docetaxel—ovarian cancer	0.000863	0.000863	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—ovarian cancer	0.000862	0.000862	CcSEcCtD
Vancomycin—Nausea—Paclitaxel—ovarian cancer	0.000855	0.000855	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000852	0.000852	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—ovarian cancer	0.000838	0.000838	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—ovarian cancer	0.000824	0.000824	CcSEcCtD
Vancomycin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000823	0.000823	CcSEcCtD
Vancomycin—Infection—Epirubicin—ovarian cancer	0.000817	0.000817	CcSEcCtD
Vancomycin—Nervous system disorder—Epirubicin—ovarian cancer	0.000807	0.000807	CcSEcCtD
Vancomycin—Dizziness—Docetaxel—ovarian cancer	0.000806	0.000806	CcSEcCtD
Vancomycin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000805	0.000805	CcSEcCtD
Vancomycin—Tachycardia—Epirubicin—ovarian cancer	0.000803	0.000803	CcSEcCtD
Vancomycin—Skin disorder—Epirubicin—ovarian cancer	0.000799	0.000799	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Vancomycin—Vomiting—Docetaxel—ovarian cancer	0.000775	0.000775	CcSEcCtD
Vancomycin—Rash—Docetaxel—ovarian cancer	0.000769	0.000769	CcSEcCtD
Vancomycin—Hypotension—Epirubicin—ovarian cancer	0.000769	0.000769	CcSEcCtD
Vancomycin—Dermatitis—Docetaxel—ovarian cancer	0.000768	0.000768	CcSEcCtD
Vancomycin—Headache—Docetaxel—ovarian cancer	0.000764	0.000764	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000761	0.000761	CcSEcCtD
Vancomycin—Infection—Doxorubicin—ovarian cancer	0.000756	0.000756	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000746	0.000746	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000745	0.000745	CcSEcCtD
Vancomycin—Insomnia—Epirubicin—ovarian cancer	0.000744	0.000744	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—ovarian cancer	0.000739	0.000739	CcSEcCtD
Vancomycin—Dyspnoea—Epirubicin—ovarian cancer	0.000733	0.000733	CcSEcCtD
Vancomycin—Nausea—Docetaxel—ovarian cancer	0.000724	0.000724	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—ovarian cancer	0.000711	0.000711	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Vancomycin—Fatigue—Epirubicin—ovarian cancer	0.000709	0.000709	CcSEcCtD
Vancomycin—Constipation—Epirubicin—ovarian cancer	0.000703	0.000703	CcSEcCtD
Vancomycin—Pain—Epirubicin—ovarian cancer	0.000703	0.000703	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—ovarian cancer	0.000679	0.000679	CcSEcCtD
Vancomycin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000657	0.000657	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—ovarian cancer	0.000656	0.000656	CcSEcCtD
Vancomycin—Urticaria—Epirubicin—ovarian cancer	0.000653	0.000653	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—ovarian cancer	0.000651	0.000651	CcSEcCtD
Vancomycin—Pain—Doxorubicin—ovarian cancer	0.000651	0.000651	CcSEcCtD
Vancomycin—Abdominal pain—Epirubicin—ovarian cancer	0.00065	0.00065	CcSEcCtD
Vancomycin—Body temperature increased—Epirubicin—ovarian cancer	0.00065	0.00065	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Vancomycin—Hypersensitivity—Epirubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—ovarian cancer	0.000605	0.000605	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—ovarian cancer	0.000602	0.000602	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—ovarian cancer	0.000602	0.000602	CcSEcCtD
Vancomycin—Asthenia—Epirubicin—ovarian cancer	0.00059	0.00059	CcSEcCtD
Vancomycin—Pruritus—Epirubicin—ovarian cancer	0.000582	0.000582	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—ovarian cancer	0.000546	0.000546	CcSEcCtD
Vancomycin—Dizziness—Epirubicin—ovarian cancer	0.000544	0.000544	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Vancomycin—Vomiting—Epirubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Vancomycin—Rash—Epirubicin—ovarian cancer	0.000519	0.000519	CcSEcCtD
Vancomycin—Dermatitis—Epirubicin—ovarian cancer	0.000518	0.000518	CcSEcCtD
Vancomycin—Headache—Epirubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—ovarian cancer	0.000503	0.000503	CcSEcCtD
Vancomycin—Nausea—Epirubicin—ovarian cancer	0.000489	0.000489	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Vancomycin—Rash—Doxorubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—ovarian cancer	0.000479	0.000479	CcSEcCtD
Vancomycin—Headache—Doxorubicin—ovarian cancer	0.000477	0.000477	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—ovarian cancer	0.000452	0.000452	CcSEcCtD
